HC Wainwright Reiterates Buy Rating on Belite Bio, Keeps $245 Target
HC Wainwright reiterated its Buy rating and $245 price target on Belite Bio. The target implies 60.4% upside from the Oct. 14 close of $152.72.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.